TRIUS THERAPEUTICS Community Page | What other sites are saying about TRIUS THERAPEUTICS

TRIUS THERAPEUTICS

(NQ: TSRX)

8.600 USD -0.030 (-0.35%)

Streaming Delayed Price / Updated: 9:37 AM EDT, Jun 19, 2013 / Add to My Watchlist

(TSRX) Community Analysis from

Related Wikinvest articles

June 19, 2013

Trius Reports New Findings on Mechanisms of Antibiotic Resistance in MRSA

(Benzinga, 9/13/10)

Trius Therapeutics, Inc. (Nasdaq: TSRX) today reported new findings on torezolid phosphate (TR-701), a second generation oxazolidinone antibiotic now in Phase 3 clinical development. The data elucidate the mechanism by which...(read more)

View all posts about Trius Therapeutics (TSRX)

Trius Therapeutics (TSRX) Company Overview

There is no analysis for TSRX yet. But you can go to Wikinvest to help create one!

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates